KRKA dd
🇸🇮Slovenia
- Country
- 🇸🇮Slovenia
- Ownership
- Public
- Established
- 1954-04-23
- Employees
- 11.7K
- Market Cap
- -
- Website
- http://www.krka.biz
Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life
Phase 4
Terminated
- Conditions
- Painful Diabetic Peripheral Neuropathy
- Interventions
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- KRKA
- Target Recruit Count
- 254
- Registration Number
- NCT04246619
- Locations
- 🇸🇮
Zdravstveni dom Koper, Koper, Slovenia
🇭🇷Opća bolnica Karlovac, Karlovac, Croatia
🇭🇷Klinička bolnica Sveti Duh, Zagreb, Croatia
Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- Drug: Co-Amlessa®Drug: Amlessa®
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- KRKA
- Target Recruit Count
- 471
- Registration Number
- NCT03738761
- Locations
- 🇦🇲
Unimed medical center, Abovyan, Armenia
🇭🇷KBC Zagreb, Klinika za bolesti srca i krvnih žila, Zagreb, Croatia
🇭🇺Biatros Kft., Biatorbágy, Hungary
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease
Completed
- Conditions
- Peripheral Arterial Disease
- Interventions
- Other: Implementation of the European Guidelines on cardiovascular Disease Prevention in Clinical Practice
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- KRKA
- Target Recruit Count
- 1455
- Registration Number
- NCT00761969
- Locations
- 🇸🇮
Department of Vascular Diseases, University of Ljubljana Medical Center, Ljubljana, Slovenia
© Copyright 2025. All Rights Reserved by MedPath